Hainan Haiyao Company Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Haiyao Company Limited with three other
companies in this sector in China:
Zhejiang Jiuzhou Pharmaceutical Co Ltd
sales of 1.72 billion Chinese Renmimbi [US$253.58 million]
of which 92%
was Production and sale of chemical active p),
Henan Lingrui Pharmaceutical Co., Ltd.
(1.85 billion Chinese Renmimbi [US$272.93 million]
of which 99%
was Health Care), and
Tianjin Tianyao Pharmaceutical, Ltd.
(1.97 billion Chinese Renmimbi [US$291.12 million]
During the year ended December of 2017, sales at
Hainan Haiyao Company Limited were 1.82 billion Chinese Renmimbi (US$269.39 million).
increase of 18.2%
versus 2016, when the company's sales were 1.54 billion Chinese Renmimbi.
Sales of Other Operating saw an increase
that was more than double the company's growth rate: sales were up
222.4% in 2017, from
41.77 million Chinese Renmimbi to 134.67 million Chinese Renmimbi.
Hainan Haiyao Company Limited also saw significant increases in sales in
Bpc (up 34.1% to 1.40 billion Chinese Renmimbi)
Storage of Chinese Medicine (up 88.7% to 27.97 million Chinese Renmimbi)
Intercompany Eliminations (up 82.0% to 38.73 million Chinese Renmimbi)
Not all segments of Hainan Haiyao Company Limited experienced an increase in sales in 2017:
sales of Preparations fell 2.8% to 583.68 million Chinese Renmimbi.